Press Releases

Perrigo is a leading global consumer-focused self-care company. Our vision is to make lives better by bringing “Quality, Affordable Self-Care Products” that consumers trust everywhere they are sold. The Company is a leading provider of health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Learn More

Perrigo Company Will Release Fourth Quarter and Fiscal Year 2005 Results on September 7, 2005
PRNewswire-FirstCall
ALLEGAN, Mich.

Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its fourth quarter and fiscal year 2005 on Wednesday, Sept. 7, 2005 at approximately 8:30 a.m. (ET). The Company will conduct a conference call at 11:00 a.m. (ET) hosted by David T. Gibbons, Perrigo's Chairman, President and Chief Executive Officer.

The conference call will be available live via webcast to interested parties on the Perrigo website http://www.perrigo.com/investor/ or by phone, 1-800-473-6123, International 973-582-2745. A taped replay of the call will be available beginning at approximately 2:30 p.m. (ET) Wednesday, Sept. 7, until midnight Friday, Sept. 16, 2005. To listen to the replay, call 1-877-519-4471, International 973-341-3080, access code 6430187.

The Perrigo Company is a leading global healthcare supplier and the world's largest manufacturer of over-the-counter (OTC) pharmaceutical and nutritional products for the store brand market. Store brand products are sold by food, drug, mass merchandise, dollar store and club store retailers under their own labels. The Company also develops, manufactures and markets prescription generic drugs, active pharmaceutical ingredients and consumer products, and operates manufacturing facilities in the United States, Israel, United Kingdom, Mexico and Germany. Visit Perrigo on the Internet (http://www.perrigo.com/ ).

SOURCE: Perrigo Company

CONTACT: Ernest J. Schenk, Manager, Investor Relations and Communication
of Perrigo Company, +1-269-673-9212, E-mail: eschenk@perrigo.com

Web site: http://www.perrigo.com/
http://www.perrigo.com/investor